Document is current
Any future updates will be listed below
-
Authors
Damoczi, Julien https://orcid.org/0009-0001-2251-7946
Knoops, Adrien
Martou, Marie-Sophie https://orcid.org/0009-0009-2225-4136
Jaumaux, Félix
Gabant, Philippe
Mahillon, Jacques
Veening, Jan-Willem https://orcid.org/0000-0002-3162-6634
Mignolet, Johann https://orcid.org/0000-0002-3721-4307
Hols, Pascal https://orcid.org/0000-0001-8749-3650
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (PDR T.0110.18)
Fonds De La Recherche Scientifique - FNRS (PDR T.0111.22)
Fonds De La Recherche Scientifique - FNRS (CDR J.0090.21)
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 5 November 2024
First Online: 14 November 2024
Competing interests
: The authors declare the following competing interests: P.H., J.Mi., J.-W.V., P.G., F.J., and J.D. declare that they are listed as inventors on patent(s) or patent application(s) related to bacteriocin production and uses. P.H. is a member of the Scientific Advisory Board of the Syngulon company. All other authors declare no competing interests.
